Influence of systemic cyclooxygenase inhibition with single-dose aspisol on kinetics of arachidonic acid metabolites in the venous effluate of transplanted kidney grafts in humans.
Storck
M
M
Department of Surgery II, University of Ulm, Germany.
Schilling
M
M
Mickley
V
V
Techt
B
B
Abendroth
D
D
D000328:Adult; D001095:Arachidonic Acids / Q000097:blood*; D001241:Aspirin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D007975:Leukotriene B4 / Q000097:blood; D008239:Lysine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011460:Prostaglandins F / Q000097:blood; D013929:Thromboxane B2 / Q000097:blood
D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D011460:Prostaglandins F; D007975:Leukotriene B4; D013929:Thromboxane B2; D003404:Creatinine; D008239:Lysine; D001241:Aspirin; C100006:prostaglandin F1; C010395:acetylsalicylic acid lysinate